Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 181 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake

Neoplasms Phase1, Phase2 Austria
France
Netherlands
Spain
United Kingdom
United States
View All

Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts

Allergy, Peanut Phase2 United States

Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study

Relapsing Multiple Sclerosis Portugal

Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria Phase3 France
Germany
Italy
Spain
United Kingdom
United States
View All

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Renal Angiomyolipoma Phase4 Taiwan

Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years

Relapsing Multiple Sclerosis Austria

A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

Sjogrens Syndrome Phase3 Argentina
Australia
Austria
Belgium
Brazil
Bulgaria
Canada
Chile
China
Colombia
Czechia
France
Germany
Greece
Guatemala
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Lithuania
Mexico
Poland
Portugal
Romania
Slovakia
South Africa
Spain
Sweden
Taiwan
Turkey
United Kingdom
United States
View All

Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP Materials

Multiple Sclerosis Switzerland

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

Hidradenitis Suppurativa Russian Federation

Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)

Sickle Cell Disease United States